To eliminate a pathogen completely, specialisation and collaboration between the different components of the immune system are needed: cells and molecules (Figure 1.11).

Collaboration and specialisation for the elimination of large or small, extracellular or intracellular pathogens. Antibodies help the agents of innate immunity to recognise and eliminate pathogens or toxins. (Reproduced from Regueiro J.R., López C., González S. & Martínez E.
(2011) Inmunología. Biología y Patología del Sistema Inmune. (4th Ed.) Editorial Médica Panamericana, Madrid.)
In addition, the immune system has organs distributed throughout the body, which are classified as primary and secondary lymphoid organs (Figure 1.1). Primary lymphoid organs are those in which lymphocytes mature to acquire the ability to recognise antigens, and comprise the bone marrow, where B cells mature, and the thymus, where T cells mature. Secondary lymphoid organs are those in which lymphocytes recognise antigen and, therefore, where clonal selection and expansion take place, followed by the effector phase. The secondary lymphoid organs are the bone marrow, the spleen, the lymph nodes and the mucosa-associated lymphoid tissue (MALT). The bone marrow is both a primary and a secondary lymphoid organ, since B cells mature in it (primary) and antibodies are produced in it (secondary).
When a pathogen manages to evade the effective innate immune barriers and establishes an infection, the mechanisms of innate and adaptive immunity are activated, combating the pathogen with cellular and humoral tools (Figure 1.12). The innate response tries to eliminate the pathogen by means of phagocytosis, the complement system and NK cells.

B cells and T cells differ in the nature of the antigens they can recognise (soluble for B cells, associated with HLA molecules for T cells) and in the second signal they require for activation (from Th cells for B cells, from APCs for T cells). Phagocytes, like B cells, recognise antigens or pathogens directly, but do not need second signals to be activated, although these enhance their function. As well as eliminating pathogens, some phagocytes initiate adaptive immunity. (Reproduced from Regueiro J.R., López C., González S. & Martínez E. (2003) Inmunología. Biología y Patología del Sistema Inmune. (3rd Ed.) Editorial Médica Panamericana,
Madrid.)
The adaptive response begins with the phagocytosis of pathogens by antigen-presenting cells (APCs), whose function is to digest the pathogen into small fragments (antigens) and present them on the surface of their membrane within a major histocompatibility complex class II molecule (MHC class II). The antigens presented in this way are recognised by a type of lymphocyte characterised by having the CD4 molecule on its membrane, called CD4+ T cells, T-helper cells (Th) or helper T cells. The interaction between the antigen–MHC class II complex of the APC and the T cell receptor (TcR) of a CD4+ T cell induces an intracellular transduction mechanism in both cells that allows the release of factors that activate other elements of the adaptive response. These elements include the other major group of T cells, characterised by having the CD8 molecule on its membrane, called CD8+ T cells, cytotoxic T cells (CTL) or cytotoxic T lymphocytes; and the B cells, which differentiate into antibody-producing plasma cells.
Once the lymphocytes have been selected, clonal expansion takes place and the effector function begins. T and B cells are able to recognise and destroy molecules and microorganisms foreign to the body's own, which together with immunological memory constitutes the main difference between lymphocytes and the other effector cells of the immune system. To carry out this recognition, they use the T cell receptor (TcR) and the B cell receptor (BcR) respectively. T and B cells act as adaptors between pathogens and the effector mechanisms of the immune system, whose characteristics are similar in the innate and adaptive responses. Cytotoxic T cells act mainly against intracellular pathogens, whereas B cells act against extracellular pathogens.